RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipharm Labs Stock

Medipharm Labs Equity 2024

Medipharm Labs Equity

53.01 M CAD

Ticker

LABS.TO

ISIN

CA58504D1006

WKN

A2N7AA

In 2024, Medipharm Labs's equity was 53.01 M CAD, a -5.35% increase from the 56 M CAD equity in the previous year.

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Medipharm Labs's Equity

Medipharm Labs's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Medipharm Labs's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Medipharm Labs's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Medipharm Labs's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Medipharm Labs’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Medipharm Labs stock

What is the equity of Medipharm Labs this year?

Medipharm Labs has equity of 53.01 M CAD this year.

What was the equity of Medipharm Labs compared to the previous year?

The equity of Medipharm Labs has increased/decreased by -5.35% decreased compared to the previous year.

What impact does a high equity have on investors of Medipharm Labs?

A high equity is advantageous for investors of Medipharm Labs as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Medipharm Labs?

A low equity can be a risk for investors of Medipharm Labs, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Medipharm Labs affect the company?

An increase in equity of Medipharm Labs can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Medipharm Labs affect the company?

A reduction in equity of Medipharm Labs can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Medipharm Labs?

Some factors that can affect the equity of Medipharm Labs include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Medipharm Labs so important for investors?

The equity of Medipharm Labs is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Medipharm Labs take to change the equity?

To change equity, Medipharm Labs can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 12/12/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipharm Labs

Our stock analysis for Medipharm Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipharm Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.